ImmunoVaccine Technologies

NCT05243524

Phase 2, Terminated, 2022, 16 people, 17 Feb 2022, clinicaltrials.gov

NCT03836352

Phase 2, Active, not recruiting, 2018, 184 people, 11 Feb 2019, clinicaltrials.gov

NCT03349450

Collaborator, Phase 2, Completed, 2018, 25 people, 21 Nov 2017, clinicaltrials.gov

NCT03332576

Phase 1, Completed, 2013, 37 people, 6 Nov 2017, clinicaltrials.gov

NCT02323230

Phase 2, Terminated, 2015, 4 people, 23 Dec 2014, clinicaltrials.gov

NCT01416038

Phase 1, Completed, 2011, 19 people, 12 Aug 2011, clinicaltrials.gov